Spleenex V NDC 44911-0539

NDC codes

FDA NDC Directory

Product NDC (as listed)44911-0539Labeler and product segments. Claims need a package NDC.

Product NDC at billing width44911-0539Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
44911-0539-1	44911053901	30 mL in 1 BOTTLE, DROPPER (44911-0539-1)Marketed from Mar 19, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Spleenex VSuffix: V
Generic name (nonproprietary): aralia quinquefolia, potassium gluconate, ginkgo biloba, magnesium gluconicum dihydricum, pancreas suis, spleen (suis), stomach (suis), germanium sesquioxide, cuprum metallicum, zincum metallicum, alpha-ketoglutaricum acidum, citricum acidum, fumaricum acidum, magnesia phosphorica, malicum acidum, pyruvic acid, succinicum acidum, naphthochinonum, aconiticum acidum, cis-, natrum oxalaceticum
Active ingredients: American ginseng — 3 [hp_X]/mLPotassium gluconate — 3 [hp_X]/mLGinkgo — 6 [hp_X]/mLMagnesium gluconate — 6 [hp_X]/mLSus scrofa pancreas — 6 [hp_X]/mLSus scrofa spleen — 6 [hp_X]/mLSus scrofa stomach — 6 [hp_X]/mLGermanium sesquioxide — 8 [hp_X]/mLCopper — 8 [hp_X]/mLZinc — 8 [hp_X]/mLOxogluric acid — 8 [hp_X]/mLAnhydrous citric acid — 8 [hp_X]/mLFumaric acid — 8 [hp_X]/mLMagnesium phosphate, Dibasic trihydrate — 8 [hp_X]/mLMalic acid — 8 [hp_X]/mLPyruvic acid — 8 [hp_X]/mLSuccinic acid — 8 [hp_X]/mLNaphthoquine — 9 [hp_X]/mLAconitic acid, (Z)- — 12 [hp_X]/mLSodium diethyl oxalacetate — 12 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Energique, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Mar 19, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Copper (Chemical structure)Decreased Coagulation Factor Activity (Physiologic effect)Decreased Embryonic Implantation (Physiologic effect)Decreased Sperm Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibit Ovum Fertilization (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 44911-0539_f4520ea3-df0f-4508-b48c-e1e5dc898cbfSPL ID f4520ea3-df0f-4508-b48c-e1e5dc898cbfSPL set ID effbaa07-239b-42f2-afd4-0eeeba7de1fdUNII 8W75VCV53Q, 12H3K5QKN9, 19FUJ2C58T, T42NAD2KHC, 9Y3J3362RY, 92AMN5J79Y, T0920P9Z9A, 96WE91N25T, 789U1901C5, J41CSQ7QDS, 8ID597Z82X, XF417D3PSL, 88XHZ13131, HF539G9L3Q, 817L1N4CKP, 8558G7RUTR, AB6MNQ6J6L, TRY8UD4E2H, OF5471ZHRR, 6CA025Y4FGUPC 0363113700503
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent; Copper-containing Intrauterine Device; Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N444911053901 followed by a unit qualifier and the quantity

Package 44911-0539-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 30, 2024.

Indications (excerpt from the label)

INDICATIONS: May temporarily relieve stomach discomfort, diarrhea, and fever.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)